Oct 18Financial & BusinessMablink Bioscience Enters an Agreement to be Acquired by LillyThe pending acquisition reflects the potential of Mablink’s existing pipeline and proprietary PSARLink™ technology for development of...
Jun 15Leadership & CorporateMablink Bioscience appoints Pejvack Motlagh, M.D., as Chief Medical OfficerLyon, France, June 15, 2023 Mablink Bioscience (“Mablink”), a biotechnologycompany dedicated to advancing cancer therapy with...
Apr 27Leadership & CorporateMablink, in the supplement of the March 2023 issue of "La Jaune et la Rouge"Interview with Jean-Guillaume LAFAY, CEO of Mablink, in the supplement of the March 2023 issue of "La Jaune et la Rouge" on the topic...